Cargando…
The promise of CD4(+)FoxP3(+) regulatory T-cell manipulation in vivo: applications for allogeneic hematopoietic stem cell transplantation
CD4(+)FoxP3(+) regulatory T cells (Tregs) are a non-redundant population critical for the maintenance of self-tolerance. Over the past decade, the use of these cells for therapeutic purposes in transplantation and autoimmune disease has emerged based on their capacity to inhibit immune activation. B...
Autores principales: | Copsel, Sabrina, Wolf, Dietlinde, Komanduri, Krishna V., Levy, Robert B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ferrata Storti Foundation
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6601084/ https://www.ncbi.nlm.nih.gov/pubmed/31221786 http://dx.doi.org/10.3324/haematol.2018.198838 |
Ejemplares similares
-
Recipient Tregs: Can They Be Exploited for Successful Hematopoietic Stem Cell Transplant Outcomes?
por: Copsel, Sabrina N., et al.
Publicado: (2022) -
NK Cell and CD4+FoxP3+ Regulatory T Cell Based Therapies for Hematopoietic Stem Cell Engraftment
por: Pierini, Antonio, et al.
Publicado: (2016) -
BET Bromodomain Inhibitors Which Permit Treg Function Enable a Combinatorial Strategy to Suppress GVHD in Pre-clinical Allogeneic HSCT
por: Copsel, Sabrina N., et al.
Publicado: (2019) -
CD4(+)CD25(high)FoxP3(+) Regulatory T-cells in Hematologic Diseases
por: Moon, Hee-Won, et al.
Publicado: (2011) -
Coexpression of CD25 and CD27 identifies FoxP3(+) regulatory T cells in inflamed synovia
por: Ruprecht, Claudia R., et al.
Publicado: (2005)